Cyclopharm Limited manufacture and sells medical equipment and radiopharmaceuticals in the Asia Pacific, Europe, Canada, and internationally. It operates through Technegas and Molecular Imaging segments. The Technegas segment offers diagnostic equipment and consumables used by physicians in the detection of pulmonary embolism. This segment also distributes third party products to the diagnostic imaging sector. The Molecular Imaging segment provides radiopharmaceuticals that are used by physicians in the detection of cancer, neurological disorders, and cardiac diseases. The company serves nuclear medicine departments. Cyclopharm Limited was founded in 1986 and is headquartered in Kingsgrove, Australia.
Cyclopharm Dividend Announcement
• Cyclopharm announced a semi annually dividend of A$0.01 per ordinary share which will be made payable on 2023-09-11. Ex dividend date: 2023-09-01
• Cyclopharm annual dividend for 2023 was A$0.01
• Cyclopharm's trailing twelve-month (TTM) dividend yield is -%
• Cyclopharm's payout ratio for the trailing twelve months (TTM) is -4.75%
Cyclopharm Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2023-09-01 | A$0.01 | semi annually | 2023-09-11 |
2023-03-27 | A$0.01 | semi annually | 2023-04-04 |
2022-09-02 | A$0.01 | semi annually | 2022-09-12 |
2022-04-04 | A$0.01 | semi annually | 2022-04-12 |
2021-09-03 | A$0.01 | semi annually | 2021-09-13 |
2021-04-01 | A$0.01 | semi annually | 2021-04-13 |
2020-09-04 | A$0.01 | semi annually | 2020-09-14 |
2020-03-30 | A$0.01 | semi annually | 2020-04-07 |
2019-09-06 | A$0.01 | semi annually | 2019-09-16 |
2019-04-05 | A$0.01 | semi annually | 2019-04-15 |
2018-09-07 | A$0.01 | semi annually | 2018-09-17 |
2018-04-06 | A$0.01 | semi annually | 2018-04-16 |
2017-09-01 | A$0.01 | semi annually | 2017-09-11 |
2017-03-31 | A$0.01 | semi annually | 2017-04-10 |
2016-09-02 | A$0.01 | semi annually | 2016-09-12 |
2016-04-11 | A$0.00 | semi annually | 2016-04-19 |
2015-10-02 | A$0.00 | semi annually | 2015-10-14 |
Cyclopharm Dividend per year
Cyclopharm Dividend growth
Cyclopharm Dividend Yield
Cyclopharm current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Cyclopharm stock? Use our calculator to estimate your expected dividend yield:
Cyclopharm Financial Ratios
Cyclopharm Dividend FAQ
Other factors to consider when evaluating Cyclopharm as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Cyclopharm stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Cyclopharm's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Cyclopharm publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Cyclopharm distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Cyclopharm are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Cyclopharm sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Cyclopharm distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Cyclopharm declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Cyclopharm's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Cyclopharm's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.